ArticleBMC veterinary research2025
PRC1, CDCA3, and CDC20 are upregulated and Treg numbers are decreased in canine massive hepatocellular carcinoma.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- OATP1A2 mRNA downregulation in canine hepatocellular carcinoma.Veterinary record open · 2026Article
- Leveraging Dog Models to Uncover Human Cancer Insights.Research square · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe mechanisms underlying the development and prognosis of hepatocellular carcinoma (HCC) differ between dogs and humans. Although genetic alterations can cause carcinogenesis, the genetic alterations in canine HCC may differ from those observed in human HCC. In humans, various signaling pathways, oncogenes, and tumor suppressor genes are associated with HCC oncogenesis. Immune cells have been reported to be associated with prognosis. In canine HCC, the genes related to oncogenesis and prognosis remain unclear. Therefore, in this study, we used RNA sequencing to comprehensively evaluate abnormally expressed genes and infer immune cell composition in canine HCC.
resultsFourteen dogs histopathologically diagnosed with HCC and four dogs with normal livers (NL) were included in this study. No HCC recurrence or metastasis was observed. A total of 260 differentially expressed genes were identified in dogs with HCC compared to those in NL dogs. Among them, 119 were downregulated and 141 were upregulated in HCC. Among the ontology and oncogenic signature gene sets, PRC1, CDCA3, and CDC20 were upregulated in the top 20 genes. Regulatory T cells (Treg) levels were decreased in the livers of dogs with HCC compared to those in normal livers.
conclusionsPRC1, CDCA3, and CDC20 were upregulated and were identified as candidate oncogenic genes in canine massive HCC. Downregulation of Tregs may be associated with prognosis in canine massive HCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.